Pandemrix
Pandemrix
Pandemrix (pronounced: pan-dem-rix) is a vaccine that was developed to protect against the influenza virus H1N1, commonly known as swine flu.
Etymology
The name "Pandemrix" is a combination of the words "pandemic" and "rix", the latter being a common suffix in the names of vaccines. The term "pandemic" is derived from the Greek words "pan", meaning "all", and "demos", meaning "people". It refers to a disease that is prevalent over a whole country or the world.
Usage
Pandemrix was primarily used during the 2009-2010 H1N1 influenza pandemic. It was developed by GlaxoSmithKline and was approved for use by the European Medicines Agency (EMA) in September 2009.
Composition
Pandemrix is an inactivated vaccine, meaning it contains killed virus. It also contains an adjuvant, a substance that enhances the body's immune response to the vaccine. The adjuvant used in Pandemrix is called AS03, and it is composed of squalene, DL-α-tocopherol and polysorbate 80.
Related Terms
- Vaccine
- Influenza
- Swine flu
- H1N1 influenza pandemic
- GlaxoSmithKline
- European Medicines Agency
- Inactivated vaccine
- Adjuvant
- AS03
- Squalene
- DL-α-tocopherol
- Polysorbate 80
External links
- Medical encyclopedia article on Pandemrix
- Wikipedia's article - Pandemrix
This WikiMD dictionary article is a stub. You can help make it a full article.
Languages: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
Urdu,
বাংলা,
తెలుగు,
தமிழ்,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
European
español,
Deutsch,
français,
русский,
português do Brasil,
Italian,
polski